Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients
转移性肾细胞癌患者接受全剂量与减量起始剂量卡博替尼治疗的毒性和临床结果分析
期刊:Clinical Genitourinary Cancer
影响因子:2.7
doi:10.1016/j.clgc.2021.11.004
Martini, Dylan J; Evans, Sean T; Liu, Yuan; Shabto, Julie M; Uner, Ogul E; Olsen, T Anders; Brown, Jacqueline T; Russler, Greta Anne; Yantorni, Lauren; Caulfield, Sarah; Goldman, Jamie M; Nazha, Bassel; Harris, Wayne B; Master, Viraj A; Kucuk, Omer; Carthon, Bradley C; Bilen, Mehmet Asim